Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Not Allowed)

    NIH plans to invite eligible US small businesses to apply for STTR grants (R41/R42) supporting collaborative research and technology development, with clinical trials not allowed.

    OverviewSimilar Grants
    OverviewSimilar Grants

    NIH and CDC Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Required)

    This upcoming NIH and CDC grant will invite eligible US small businesses to apply for SBIR funding for innovative research requiring clinical trials, pending program reauthorization.

    HHS-NIH11Due Apr 5, 2029

    Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)

    The NIH will soon offer grants to support early-career scientists at US small businesses, funding both research and entrepreneurial training, with required mentoring for first-time principal investigators.

    HHS-NIH11Forecasted Jan 5, 2027Forecasted

    SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Not Allowed)

    NIH will soon offer funding for small businesses with recent SBIR/STTR Phase II/IIB awards to support technical assistance and late-stage R&D for commercialization, excluding clinical trials.

    HHS-NIH11Due Apr 5, 2029

    Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)

    This upcoming NIH and CDC grant supports early-career scientists at US small businesses with funding, entrepreneurial training, and mentoring to help them transition into entrepreneurship.

    HHS-NIH11Forecasted Jan 5, 2027Forecasted

    NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

    The NIH, CDC and FDA Small Business Innovation Research Grant helps US small businesses develop and commercialize cutting-edge health technologies, from early feasibility through advanced research.

    HHS-NIH11Due Apr 5, 2027